Private Equity

Jimmy Hutcheson brings his media revival expertise from SPIN Magazine to the Playing For Change Foundation, aiming to boost its global youth arts programs.

Following a major investment, Trialbee appoints a seasoned leader to its board, signaling a push for dominance in AI-driven clinical trial recruitment.

Amid Europe's market comeback, DWS launches the XEML ETF, offering a targeted way for U.S. investors to tap into the continent's top 40 companies.

Private equity firm Astara Capital Partners hires a top talent chief, signaling a strategic shift from financial engineering to human-led operational growth.

PatientPoint founder Mike Collette joins Carefeed's board, signaling a major push to tackle senior living's operational crises with proven tech leadership.

A new Edmonton health centre embeds pharmacy services directly into patient care, aiming to fix a fragmented system and empower local pharmacists.

Easterly Asset Management's deal to absorb Olstein's funds marks a key industry consolidation, promising lower fees and a unified value investing powerhouse.

The private equity firm hires Laura Noisten to lead leveraged finance, a strategic move to fuel growth in the complex aerospace and defense tech sector.

PainTEQ's landmark deal, crowned 'Deal of the Year,' showcases a new model for medtech growth and its patient-first mission in pain management.

Risk Theory's first MGA acquisition of Roundhill Express signals a new buy-and-build era, targeting the high-stakes NYC specialty property market.

REPKON USA rebrands as Paligen, signaling a new era of domestic defense manufacturing fueled by a landmark TNT contract and strategic acquisitions.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

In a tough PE climate, Truelink Capital rapidly closes its second fund at its $2B hard cap, signaling strong investor belief in its operational strategy.

VLS Environmental Solutions expands its hazardous waste network by acquiring California-based IDR, a strategic move in a highly regulated market.

An Austin startup is launching an intelligence platform to help marketing leaders see a company's red flags before accepting a misaligned leadership role.

Praesidian Capital unites iconic model train maker Lionel with hobby giant Round 2, creating a new collectibles empire focused on innovation and growth.

Agenus activates a key manufacturing pact with Zydus, scaling production for its promising BOT+BAL cancer therapy ahead of regulatory filings and market launch.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

Celebrating 80 years, Aveeno renews its foundational ties with Mayo Clinic, launching a new era of oat science research for compromised skin.

Uranium Energy Corp reports a strong quarter with new mine completion, robust finances, and a strategic push to build a fully domestic nuclear fuel cycle.